The Rho-ROCK System as a New Therapeutic Target for Preventing Interstitial Fibrosis

Drug News and Perspectives

Volumn 17, Issue 1, 2004, Pages 29-34

  Moriyama, Toshiki ^a,b   Nagatoya, Katsuyuki ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; RHO ASSOCIATED COILED COIL FORMING PROTEIN KINASE; RHO KINASE; STATINE DERIVATIVE; UNCLASSIFIED DRUG;

DISEASE COURSE; DRUG TARGETING; ENZYME INHIBITION; HUMAN; KIDNEY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LEUKOPENIA; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; AMIDES; ANIMALS; FIBROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; KIDNEY TUBULES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RHO GTP-BINDING PROTEINS; URETERAL OBSTRUCTION;

EID: 1842529005     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.1.829023     Document Type: Review

References (43)

1. Madaule, P. and Axel, R. A novel ras-related gene family. Cell 1985, 41: 31-40.
2. Ridley, A.J. and Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fiber in response to growth factors. Cell 1992, 70: 389-99.
3. Hirata, K., Kikuchi, A., Sasaki, T. et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992, 267: 8719-22.
4. Mabuchi, I., Hamaguchi, Y., Fujimoto, H., Morii, N., Mishima, M. and Narumiya, S. A rho-like protein is involved in the organisation of the contractile ring in dividing sand dollar eggs. Zygote 1993, 1: 325-31.
5. Yamamoto, M., Marui, N., Sakai, T. et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of cell cycle. Oncogene 1993, 8: 1449-55.
6. Aoki, H., Izumo, S. and Sadoshima, J. Angiotensin II activates RhoA in cardiac myocytes: A critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998, 82: 666-76.
7. Aikawa, R., Komuro, I., Nagai, R. and Yazaki, Y. Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes. Mol Cell Biochem 2000, 212: 177-82.
8. Rankin, S., Morii, N., Narumiya, S. and Rozengurt, E. Botulinum C3 exoenzyme blocks the tyrosine phosphorylation of p125FAK and paxillin induced by bombesin and endothelin. FEBS Lett 1994, 354: 315-9.
9. Uehata, M., Ishizaki, T., Satoh, H. et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389: 990-4.
10. Ishizaki, T., Uehata, M., Tamechika, I. et al. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 2000, 57: 976-83.
11. Asano, T., Ikegaki, I., Satoh, S. et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 1987, 241: 1033-40.
12. Nagumo, H., Sasaki, Y., Ono, Y., Okamoto, H., Seto, M. and Takuwa, Y. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 2000, 278: C57-65.
13. Utsunomiya, T., Satoh, S., Ikegaki, I., Toshima, Y., Asano, T. and Shimokawa, H. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor in a canine model of effort angina. Br J Pharmacol 2001, 134: 1724-30.
14. Shibuya, M., Suzuki, Y., Sugita, K. et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 1992, 76: 571-7.
15. Wang, H., Eto, M., Steers, W.D., Somlyo, A.P. and Somlyo, A.V. RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem 2002, 277: 30614-21.
16. Ando, Y., Moriyama, T., Oka, K. et al. Enhanced interstitial expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy. Nephrol Dial Transplant 1999, 14: 1408-17.
17. Moriyama, T. and Imai, E. Role of myofibroblasts in progressive renal diseases. Cotrib Nephrol 2003, 139: 120-40.
18. Hall, A. Rho GTPases and the actin cytoskeleton. Science 1998, 279: 509-14.
19. Yee, H.F.J. Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. Hepatology 1998, 28: 843-50.
20. Nagatoya, K., Moriyama, T., Kawada, N. et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002, 61: 1684-95.
21. Risdon, R.A., Sloper, J.C. and De Wardener, H.E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968, 2: 363-6.
22. Nath, K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992, 20: 1-17.
23. D'Amico, G., Ferrario, F. and Rastaldi, M.P. Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage. Am J Kidney Dis 1995, 26: 124-32.
24. Bohle, A., Muller, G.A., Wehrmann, M., Mackensen-Haen, S. and Xiao, J.C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 1996, Suppl. 54: S2-9.
25. Ziyadeh, F.N. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 1996, Suppl. 54: S10-13.
26. Seasholtz, T.M., Majumdar, M., Kaplan, D.D. and Brown, J.H. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res 1999, 84: 1186-93.
27. Iwamoto, H., Nakamuta, M., Tada, S., Sugimoto, R., Enjoji, M. and Nawata, H. A p160ROCK-specific inhibitor, Y-27632. attenuates rat hepatic stellate cell growth. J Hepatol 2000, 32: 762-70.
28. Sawada, N., Itoh, H., Ueyama, K. et al. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 2000, 101: 2030-3.
29. Weber, J.D., Hu, W., Jefcoat, S.C., Jr., Raben, D.M. and Baldassare, J.J. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem 1997, 272: 32966-71.
30. Fukata, Y., Oshiro, N., Kinoshita, N. et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 1999, 145: 347-61.
31. Adachi, T., Vita, R., Sannohe, S. et al. The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils. J Immunol 2001, 167: 4609-15.
32. Kawada, N., Seki, S., Kuroki, T. and Kaneda, K. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun 1999, 266: 296-300.
33. Shimizu, Y., Dobashi, K., Iizuka, K. et al. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am J Respir Crit Care Med 2001, 163: 210-7.
34. Yoshioka, K., Nakamori, S. and Itoh, K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999, 59: 2004-10.
35. Manning, T.J.J., Parker, J.C. and Sontheimer, H. Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil Cytoskeleton 2000, 45: 185-99.
36. Gupta, S., Clarkson, M.R., Duggan, J. and Brady, H.R. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000, 1389-99.
37. Heusinger-Ribeiro, J., Eberlein, M., Wahab, N.A. and Goppelt-Struebe, M. Expression of connective tissue growth factor in human renal fibroblasts: Regulatory roles of RhoA and cAMP. J Am Soc Nephrol 2001, 12: 1853-61.
38. Klahr, S., Ishidoya, S. and Morrissey, J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 1995, 26: 141-6.
39. Mack, C.P., Somlyo, A.V., Hautmann, M., Somlyo, A.P. and Owens, G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 2001, 276: 341-7.
40. Satoh, S., Yamaguchi, T., Hitomi, A. et al. Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 2002, 455: 169-74.
41. Terada, Y., Inoshita, S., Nakashima, O. et al. Lovastatin inhibits mesangial cell proliferation via p27Kip1. J Am Soc Nephrol 1998, 9: 2235-43.
42. Yoshimura, A., Inui, K., Nemoto, T. et al. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 1998, 9: 2027-39.
43. Moriyama, T., Kawada, N., Nagatoya, K. et al. Fluvastatin suppresses the oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001, 59: 2095-103.